Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features

Publication date: April 2017
Source:European Journal of Cancer, Volume 75
Author(s): Lavinia Spain, Thomas Schmid, Martin Gore, James Larkin




http://ift.tt/2mmSG1W